Additionally, MET activated and triggered the AKT signaling pathway, which subsequently stimulated FOXM1 expression in lung adenocarcinoma cells, and this effect was partially inhibited by LY294002. The gene discussed is AKT1; the disease is lung adenocarcinoma.